A Necessary Role of miR-221 and miR-222 in Vascular Smooth Muscle Cell Proliferation and Neointimal Hyperplasia

被引:539
|
作者
Liu, Xiaojun [1 ]
Cheng, Yunhui [1 ]
Zhang, Shuo [1 ]
Lin, Ying [1 ]
Yang, Jian [1 ]
Zhang, Chunxiang [1 ]
机构
[1] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Anesthesiol, RNA & Cardiovasc Res Lab, Newark, NJ 07101 USA
关键词
microRNAs; vascular smooth muscle cells; gene regulation; proliferation; vascular disease; RAT CAROTID-ARTERY; MICRORNA EXPRESSION; CARDIOVASCULAR BIOLOGY; DOWN-REGULATION; BREAST-CANCER; MESSENGER-RNA; PROGRESSION; P27(KIP1); GROWTH; INHIBITION;
D O I
10.1161/CIRCRESAHA.108.185363
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
MicroRNAs (miRNAs) comprise a novel class of endogenous, small, noncoding RNAs that negatively regulate gene expression. Functionally, an individual miRNA is as important as a transcription factor because it is able to regulate the expression of its multiple target genes. Recently, miR-221 and miR-222 have been found to play a critical role in cancer cell proliferation. However, their roles in vascular smooth muscle cell (VSMC) biology are currently unknown. In the present study, the time course changes and cellular distribution of miR-221 and miR-222 expression were identified in rat carotid arteries after angioplasty, in which their expression was upregulated and localized in VSMCs in the injured vascular walls. In cultured VSMCs, miR-221 and miR-222 expression was increased by growth stimulators. Knockdown of miR-221 and miR-222 resulted in decreased VSMC proliferation in vitro. Using both gain-of-function and loss-of-function approaches, we found that p27(Kip1) and p57(Kip2) were 2 target genes that were involved in miR-221- and miR-222-mediated effect on VSMC growth. Finally, knockdown of miR-221 and miR-222 in rat carotid arteries suppressed VSMC proliferation in vivo and neointimal lesion formation after angioplasty. The results indicate that miR-221 and miR-222 are novel regulators for VSMC proliferation and neointimal hyperplasia. These findings may also represent promising therapeutic targets in proliferative vascular diseases. (Circ Res. 2009; 104:476-487.)
引用
收藏
页码:476 / U125
页数:27
相关论文
共 50 条
  • [31] The microRNA miR-34c inhibits vascular smooth muscle cell proliferation and neointimal hyperplasia by targeting stem cell factor
    Choe, Nakwon
    Kwon, Jin-Sook
    Kim, Yong Sook
    Eom, Gwang Hyeon
    Ahn, Young Keun
    Baik, Yung Hong
    Park, Hyun-Young
    Kook, Hyun
    CELLULAR SIGNALLING, 2015, 27 (06) : 1056 - 1065
  • [32] Efficacy of DMBG and gemcitabine as a combination treatment on advanced pancreatic cancer, and their effect on miR-190, miR-196a, miR-221 and miR-222
    Li, Chuanbao
    Ni, Lina
    Cui, Xijun
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2020, 13 (02): : 582 - 589
  • [33] Adenovirus-mediated shRNAs for co-repression of miR-221 and miR-222 expression and function in glioblastoma cells
    Wang, Xuan
    Han, Lei
    Zhang, Anling
    Wang, Guangxiu
    Jia, Zhifan
    Yang, Yang
    Yue, Xiao
    Pu, Peiyu
    Shen, Changhong
    Kang, Chunsheng
    ONCOLOGY REPORTS, 2011, 25 (01) : 97 - 105
  • [34] MiR-93 regulates vascular smooth muscle cell proliferation, and neointimal formation through targeting Mfn2
    Feng, Shengdong
    Gao, Lu
    Zhang, Dianhong
    Tian, Xinyu
    Kong, Lingyao
    Shi, Huiting
    Wu, Leiming
    Huang, Zhen
    Du, Binbin
    Liang, Cui
    Zhang, Yanzhou
    Yao, Rui
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2019, 15 (12): : 2615 - 2626
  • [35] Hsa_circ_0001402 alleviates vascular neointimal hyperplasia through a miR-183-5p-dependent regulation of vascular smooth muscle cell proliferation, migration, and autophagy
    Lin, Jia-Jie
    Chen, Rui
    Yang, Li-Yun
    Gong, Miao
    Du, Mei-Yang
    Mu, Shi-Qing
    Jiang, Ze-An
    Li, Huan-Huan
    Yang, Yang
    Wang, Xing-Hui
    Wang, Si-Fan
    Liu, Ke-Xin
    Cao, Shan-Hu
    Wang, Zhao-Yi
    Zhao, An-Qi
    Yang, Shu-Yan
    Li, Cheng
    Sun, Shao-Guang
    JOURNAL OF ADVANCED RESEARCH, 2024, 60 : 93 - 110
  • [36] HMGB1 induces the overexpression of miR-222 and miR-221 and increases growth and motility in papillary thyroid cancer cells
    Mardente, Stefania
    Mari, Emanuela
    Consorti, Fabrizio
    Di Gioia, Cira
    Negri, Rodolfo
    Etna, Marilena
    Zicari, Alessandra
    Antonaci, Alfredo
    ONCOLOGY REPORTS, 2012, 28 (06) : 2285 - 2289
  • [37] miR-221/222 Are Involved in Response to Sunitinib Treatment in Metastatic Renal Cell Carcinoma
    Khella, Heba W. Z.
    Butz, Henriett
    Ding, Qiang
    Rotondo, Fabio
    Evans, Kenneth R.
    Kupchak, Peter
    Dharsee, Moyez
    Latif, Ashraf
    Pasic, Maria D.
    Lianidou, Evi
    Bjarnason, Georg A.
    Yousef, George M.
    MOLECULAR THERAPY, 2015, 23 (11) : 1748 - 1758
  • [38] miR-221 modulates skeletal muscle satellite cells proliferation and differentiation
    Buwei Liu
    Yu Shi
    Hongbing He
    Mingcheng Cai
    Wudian Xiao
    Xue Yang
    Shiyi Chen
    Xianbo Jia
    Jie Wang
    Songjia Lai
    In Vitro Cellular & Developmental Biology - Animal, 2018, 54 : 147 - 155
  • [39] Expression Profile Analysis of miR-221 and miR-222 in Different Tissues and Head Kidney Cells of Cynoglossus semilaevis, Following Pathogen Infection
    Yan, Hui
    Chen, Yadong
    Zhou, Shun
    Li, Chao
    Gong, Guangye
    Chen, Xuejie
    Wang, Tianzi
    Chen, Songlin
    Sha, Zhenxia
    MARINE BIOTECHNOLOGY, 2016, 18 (01) : 37 - 48
  • [40] High level of miR-221/222 confers increased cell invasion and poor prognosis in glioma
    Zhang, Chunzhi
    Zhang, Junxia
    Hao, Jianwei
    Shi, Zhendong
    Wang, Yingyi
    Han, Lei
    Yu, Shizhu
    You, Yongping
    Jiang, Tao
    Wang, Jinhuan
    Liu, Meili
    Pu, Peiyu
    Kang, Chunsheng
    JOURNAL OF TRANSLATIONAL MEDICINE, 2012, 10